5 completed, 2 terminated, 1 unknown. 8 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 5, Terminated 2, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Foot Ulcer, Diabetic: new trials by email Literature Review of Foot Ulcer, Diabetic trials Research Report on Foot Ulcer, Diabetic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Micro-mobile Foot Compression and Diabetic Foot Avex Footbeat - Diabetes, PAD | Phase 2 | Completed | Baylor College of Medicine | 30 | 2017-05-02 | 2021-10-28 |
| Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2 dac-MSCs, MSCs, Fitostimoline - Foot Ulcer, Diabetic | Phase 1 / Phase 2 | Unknown | Universidad Autónoma de Bucaramanga | 51 | 2017-01-01 | 2016-10-24 |
| Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers NorLeu3-A(1-7) in a gel formulation - Foot Ulcer, Diabetic, Diabetic Foot | Phase 2 | Completed | US Biotest, Inc. | 78 | 2008-10-01 | 2012-09-27 |
| Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections Topical Dermacyn, Topical Dermacyn and Levofloxacin, Topical Saline and Levofloxacin - Foot Ulcer, Diabetic | Phase 2 | Completed | Oculus Innovative Sciences, Inc. | 65 | 2007-05-01 | 2008-01-14 |
| Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers MRE0094, Vehicle gel - Foot Ulcer, Diabetic, Diabetes Complications | Phase 2 | Terminated | Pfizer | 16 | 2006-06-01 | 2012-06-01 |
| A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers placebo, telbermin - Foot Ulcer, Diabetic | Phase 2 | Completed | Genentech, Inc. | 170 | 2006-01-01 | 2013-01-25 |
| Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers MRE0094 - Foot Ulcer, Diabetic, Diabetes Complications | Phase 2 | Completed | Pfizer | 322 | 2005-12-01 | 2012-06-01 |
| Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients bemiparin (low molecular weight heparin) - Foot Ulcer, Diabetic, Diabetic Angiopathies | Phase 2 / Phase 3 | Terminated | Spanish National Health System | 84 | 2001-06-01 | 2006-11-14 |
Diabetic Foot (8) · Diabetes Mellitus (4) · Diabetes Complications (2) · Foot Ulcer (2) · Infections (2) · digital ulcers (2) · Diabetic Angiopathies (1) · Diabetic Neuropathies (1) · Lymphatic Diseases (1) · Neuritis (1) · Peripheral Vascular Diseases (1) · Ulcer (1) · Wounds and Injuries (1)
Cardiovascular Diseases (8) · Endocrine System Diseases (8) · Leg Ulcer (8) · Skin Diseases (8) · Skin Ulcer (8) · Skin and Connective Tissue Diseases (8) · Vascular Diseases (8) · Diabetic Angiopathies (7) · Diabetic Neuropathies (7) · Diabetes Complications (6) · Foot Ulcer (6) · Diabetes Mellitus (4) · Glucose Metabolism Disorders (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4)
2-(2-(4-chlorophenyl)ethoxy)adenosine (2) · Cell- and Tissue-Based Therapy (1) · Flour (1) · Heparin, Low-Molecular-Weight (1) · Levofloxacin (1) · Saline Solution (1) · Sodium Chloride (1) · aclerastide (1) · bemiparin (1) · dermacyn (1) · norLeu3-A(1-7) (1)
Pfizer (2) · Baylor College of Medicine (1) · Genentech, Inc. (1) · Oculus Innovative Sciences, Inc. (1) · Spanish National Health System (1) · US Biotest, Inc. (1) · Universidad Autónoma de Bucaramanga (1)
United States (5)
Andres Gutierrez, M.D., Ph.D. (1) · Claudia L Sossa-Melo, MD (1) · Manuel Rullan, MD (1) · Pual Kwon, M.D. (1) · Robert L. Rolleri, Pharm.D. (1)